23 Participants Needed

e-Health Intervention for Cancer of the Female Reproductive System

Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: City of Hope Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial studies how well the 'Day by Day' online program helps patients with advanced gynecologic cancer manage their fears about cancer progression. The program includes group sessions, self-study activities, and periodic updates to teach skills for reducing anxiety and worries.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the e-Health Intervention (Day-by-Day) treatment for cancer of the female reproductive system?

Research shows that online interventions can improve health outcomes like quality of life and symptom management for patients with gynecological cancers. Additionally, digital health strategies have been effective in enhancing the quality of life for breast cancer survivors, suggesting potential benefits for similar interventions in other female reproductive cancers.12345

Is the e-Health Intervention generally safe for humans?

Research on similar e-Health interventions for cancer patients, such as those for weight loss and self-management, suggests they are generally safe. These studies focused on improving quality of life and managing symptoms without reporting significant safety concerns.678910

How is the e-Health Intervention (Day-by-Day) treatment different from other treatments for cancer of the female reproductive system?

The e-Health Intervention (Day-by-Day) is unique because it leverages digital technology to provide accessible, tailored support and information for women with gynecological cancer, potentially improving their quality of life and addressing psychosocial and physical burdens in a way that traditional treatments may not.2341112

Research Team

AR

Anne Reb

Principal Investigator

City of Hope Medical Center

Eligibility Criteria

This trial is for English-speaking women over 18 with stage III or IV gynecologic cancer (ovarian, endometrial, cervical, vulvar/vaginal), at least 3 months post-diagnosis. They must have significant fear of their cancer progressing as measured by a specific questionnaire. Those in hospice care, with severe depression, or unable to follow the study plan are excluded.

Inclusion Criteria

I am 18 years old or older.
My cancer is either improving or getting worse.
I am a woman diagnosed with advanced GYN cancer more than 3 months ago.
See 2 more

Exclusion Criteria

You are currently receiving care in a hospice.
You have been diagnosed with severe depression using the Patient Health Questionnaire (PHQ-9).
Non-English speaking
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Development

Patients complete surveys and participate in focus groups to adapt the intervention into a hybrid format

Not specified

DBD Intervention

Patients receive DBD intervention consisting of group and web-based self-study sessions, check-in calls, videos, and handouts

6 weeks

Follow-up

Participants are monitored for fear of progression and secondary outcomes such as distress, anxiety, and depression

6 weeks

Treatment Details

Interventions

  • e-Health Intervention (Day-by-Day)
Trial OverviewThe trial tests an e-health intervention called 'Day-by-Day' designed to manage fears about cancer progression in patients with advanced gynecologic cancers. It's based on the 'Conquer Fear' program and includes discussions, informational media interventions, questionnaires and telephone support to help reduce anxiety.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Supportive Care (DBD)Experimental Treatment5 Interventions
Patients receive DBD intervention consisting of group and web-based self-study sessions and check-in calls on study. Patients also watch videos and receive handouts to reinforce the group sessions.

Find a Clinic Near You

Who Is Running the Clinical Trial?

City of Hope Medical Center

Lead Sponsor

Trials
614
Recruited
1,924,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

The pilot study involving 50 breast cancer survivors demonstrated that the e-health platform 'Healthy.me' was generally perceived as a useful resource for tailored health and lifestyle information, particularly in the first month of use.
However, user engagement declined significantly from 76% at one month to 48% at four months, primarily due to time constraints, limited content updates, and technical issues, indicating the need for ongoing improvements to enhance user retention.
An e-health strategy to facilitate care of breast cancer survivors: A pilot study.Tiong, SS., Koh, ES., Delaney, G., et al.[2022]
This study will compare the effectiveness of a mobile health application combined with face-to-face rehabilitation versus the app alone in improving the Quality of Life for breast cancer survivors, involving women aged 25 to 75 with specific health criteria.
The primary outcome will be assessed after 8 weeks, focusing on Quality of Life, while secondary outcomes will include body composition, functionality, cognitive function, and mental health, highlighting the importance of both technology and professional support in cancer rehabilitation.
Integral strategy to supportive care in breast cancer survivors through occupational therapy and a m-health system: design of a randomized clinical trial.Lozano-Lozano, M., Martรญn-Martรญn, L., Galiano-Castillo, N., et al.[2022]
Online interventions have been found to significantly improve the quality of life and body image in patients with gynecological cancer, based on a review of 24 studies.
However, the effects of these interventions on symptom distress, social support, psychological distress, and sexual well-being remain inconclusive, indicating a need for further research with more rigorous study designs.
The effectiveness of online interventions for patients with gynecological cancer: An integrative review.Lin, H., Ye, M., Chan, SW., et al.[2021]

References

An e-health strategy to facilitate care of breast cancer survivors: A pilot study. [2022]
Integral strategy to supportive care in breast cancer survivors through occupational therapy and a m-health system: design of a randomized clinical trial. [2022]
The effectiveness of online interventions for patients with gynecological cancer: An integrative review. [2021]
Online-based interventions for sexual health among individuals with cancer: a systematic review. [2018]
Effectiveness of Digital Health on the Quality of Life of Long-Term Breast Cancer Survivors: A Systematic Review. [2023]
Mobile web-based self-management program for breast cancer patients with chemotherapy-induced amenorrhoea: A quasi-experimental study. [2022]
Mobile Physical Activity Intervention for Breast Cancer Patients During Chemotherapy. [2018]
Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy. [2018]
A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Online interventions for sexual health in cancer. [2021]
Digital support for living with and beyond gynaecological cancer. [2021]